Discovery of imidazole carboxamides as potent and selective CCK1R agonists

Bioorg Med Chem Lett. 2008 Aug 1;18(15):4393-6. doi: 10.1016/j.bmcl.2008.06.057. Epub 2008 Jun 20.

Abstract

High-throughput screening revealed diaryl pyrazole 3 as a selective albeit modest cholecystokinin 1 receptor (CCK1R) agonist. SAR studies led to the discovery and optimization of a novel class of 1,2-diaryl imidazole carboxamides. Compound 44, which was profiled extensively, showed good in vivo mouse gallbladder emptying (mGBE) and lean mouse overnight food intake (ONFI) reduction activities.

MeSH terms

  • Amides / chemical synthesis*
  • Amides / chemistry
  • Amides / pharmacology*
  • Animals
  • Anti-Obesity Agents / chemical synthesis*
  • Anti-Obesity Agents / chemistry
  • Anti-Obesity Agents / pharmacology*
  • Chemokines, CC
  • Combinatorial Chemistry Techniques
  • Eating / drug effects
  • Gallbladder Emptying / drug effects
  • Humans
  • Imidazoles / chemical synthesis*
  • Imidazoles / chemistry
  • Imidazoles / pharmacology*
  • Mice
  • Molecular Structure
  • Receptors, Cholecystokinin / agonists*
  • Structure-Activity Relationship

Substances

  • Amides
  • Anti-Obesity Agents
  • Ccl28 protein, mouse
  • Chemokines, CC
  • Imidazoles
  • Receptors, Cholecystokinin